Downregulated ADAMTS1 Incorporating A2M Contributes to Tumorigenesis and Alters Tumor Immune Microenvironment in Lung Adenocarcinoma
Open Access
- 16 May 2022
- Vol. 11 (5), 760
- https://doi.org/10.3390/biology11050760
Abstract
Lung adenocarcinoma (LUAD) still holds the most dreadful clinical outcomes worldwide. Despite advanced treatment strategies, there are still some unmet needs. Next-generation sequencing of large-scale cancer genomics discovery projects combined with bioinformatics provides the opportunity to take a step forward in meeting clinical conditions. Based on in-house and The Cancer Genome Atlas (TCGA) cohorts, the results showed decreased levels of ADAMTS1 conferred poor survival compared with normal parts. Gene set enrichment analyses (GSEA) indicated the negative correlation between ADAMTS1 and the potential roles of epithelial–mesenchymal transition (EMT), metastasis, and poor prognosis in LUAD patients. With the knockdown of ADAMTS1, A549 lung cancer cells exhibited more aggressive behaviors such as EMT and increased migration, resulting in cancer metastasis in a mouse model. The pathway interaction network disclosed the linkage of downregulated α2-macroglobulin (A2M), which regulates EMT and metastasis. Furthermore, immune components analysis indicated a positive relationship between ADAMTS1 and the infiltrating levels of multiple immune cells, especially anticancer CD4+ T cells in LUAD. Notably, ADAMTS1 expression was also inversely correlated with the accumulation of immunosuppressive myeloid-derived suppressor cells and regulatory T cells, implying the downregulated ADAMTS1 mediated immune adjustment to fit the tumor survival disadvantages in LUAD patients. In conclusion, our study indicates that ADAMTS1 interacts with A2M in regulating EMT and metastasis in LUAD. Additionally, ADAMTS1 contributes to poor prognosis and immune infiltration in LUAD patientsFunding Information
- Ministry of Science and Technology, Taiwan (110-2314-B-037-124-MY3; MOST 10-2314-B-037-126-MY2)
- Kaohsiung Medical University Hospital Research Funding (KMUH-110-0R14; KMUH-110-0R17)
This publication has 38 references indexed in Scilit:
- Prospero‐related homeobox 1 drives angiogenesis of hepatocellular carcinoma through selectively activating interleukin‐8 expressionJournal of Hepatology, 2017
- The miR-181d-regulated metalloproteinase Adamts1 enzymatically impairs adipogenesis via ECM remodelingCell Death & Differentiation, 2016
- The metalloproteinase ADAMTS1: A comprehensive review of its role in tumorigenic and metastatic pathwaysInternational Journal of Cancer, 2013
- Decreased expression of ADAMTS-1 in human breast tumors stimulates migration and invasionMolecular Cancer, 2013
- Hypoxia-regulated target genes implicated in tumor metastasisJournal of Biomedical Science, 2012
- α2-Macroglobulin Inhibits the Malignant Properties of Astrocytoma Cells by Impeding β-Catenin SignalingCancer Research, 2010
- Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectivelyOncogene, 2005
- ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining PlatformNeoplasia, 2004
- Growth Factor-Binding Sequence in Human α2-Macroglobulin Targets the Receptor-Binding Site in Transforming Growth Factor-βBiochemistry, 2003
- ADAMTS-1 Is an Active Metalloproteinase Associated with the Extracellular MatrixOnline Journal of Public Health Informatics, 1999